FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385751864> ?p ?o ?g. }

• W4385751864 abstract "Globally, more than 58 million people are chronically infected with Hepatitis C virus (HCV) with 1.5 million new infections occurring each year. An effective vaccine for HCV is therefore a major unmet medical and public health need. Since HCV rapidly accumulates mutations, vaccines must elicit the production of broadly neutralising antibodies (bnAbs) in a reproducible fashion. Decades of research have generated a number of HCV vaccine candidates. Based on the available data and research through clinical development, a vaccine antigen based on the E1E2 glycoprotein complex appears to be the best choice, but robust induction of humoral and cellular responses leading to virus neutralisation has not yet been achieved. One issue that has arisen in developing an HCV vaccine (and many other vaccines as well) is the platform used for antigen delivery. The majority of viral vaccine trials have employed subunit vaccines. However, subunit vaccines often have limited immunogenicity, as seen for HCV, and thus multiple formats must be examined in order to elicit a robust anti-HCV immune response. Nanoparticle vaccines are gaining prominence in the field due to their ability to facilitate a controlled multivalent presentation and trafficking to lymph nodes, where they can interact with both arms of the immune system. This review discusses the potential for development of a nanoparticle-based HCV E1E2 vaccine, with an emphasis on the potential benefits of such an approach along with the major challenges facing the incorporation of E1E2 into nanoparticulate delivery systems and how those challenges can be addressed." @default.
• W4385751864 created "2023-08-12" @default.
• W4385751864 creator A5004023398 @default.
• W4385751864 creator A5038413616 @default.
• W4385751864 creator A5041786396 @default.
• W4385751864 date "2023-08-11" @default.
• W4385751864 modified "2023-10-13" @default.
• W4385751864 title "Prospects for developing an Hepatitis C virus E1E2‐based nanoparticle vaccine" @default.
• W4385751864 cites W1025483849 @default.
• W4385751864 cites W1562770137 @default.
• W4385751864 cites W1569603086 @default.
• W4385751864 cites W1679889097 @default.
• W4385751864 cites W1963707175 @default.
• W4385751864 cites W1967491261 @default.
• W4385751864 cites W1970880058 @default.
• W4385751864 cites W1985680307 @default.
• W4385751864 cites W1991220107 @default.
• W4385751864 cites W1998738356 @default.
• W4385751864 cites W2003869981 @default.
• W4385751864 cites W2005888814 @default.
• W4385751864 cites W2007013372 @default.
• W4385751864 cites W2010309004 @default.
• W4385751864 cites W2016104233 @default.
• W4385751864 cites W2017359325 @default.
• W4385751864 cites W2018056882 @default.
• W4385751864 cites W2022077416 @default.
• W4385751864 cites W2024763248 @default.
• W4385751864 cites W2028757382 @default.
• W4385751864 cites W2031004199 @default.
• W4385751864 cites W2036907186 @default.
• W4385751864 cites W2037494007 @default.
• W4385751864 cites W2043080047 @default.
• W4385751864 cites W2045149167 @default.
• W4385751864 cites W2048756080 @default.
• W4385751864 cites W2049190944 @default.
• W4385751864 cites W2054802322 @default.
• W4385751864 cites W2057292812 @default.
• W4385751864 cites W2058115636 @default.
• W4385751864 cites W2059229991 @default.
• W4385751864 cites W2064778609 @default.
• W4385751864 cites W2089638478 @default.
• W4385751864 cites W2090297731 @default.
• W4385751864 cites W2099855191 @default.
• W4385751864 cites W2100260641 @default.
• W4385751864 cites W2101285175 @default.
• W4385751864 cites W2101494860 @default.
• W4385751864 cites W2102253058 @default.
• W4385751864 cites W2106058187 @default.
• W4385751864 cites W2109474100 @default.
• W4385751864 cites W2110443462 @default.
• W4385751864 cites W2118749067 @default.
• W4385751864 cites W2120321866 @default.
• W4385751864 cites W2134867985 @default.
• W4385751864 cites W2135726816 @default.
• W4385751864 cites W2144805869 @default.
• W4385751864 cites W2148541719 @default.
• W4385751864 cites W2150983148 @default.
• W4385751864 cites W2153130425 @default.
• W4385751864 cites W2156580403 @default.
• W4385751864 cites W2162909292 @default.
• W4385751864 cites W2172319351 @default.
• W4385751864 cites W2195593931 @default.
• W4385751864 cites W2261411023 @default.
• W4385751864 cites W2288320856 @default.
• W4385751864 cites W2298951702 @default.
• W4385751864 cites W2414133006 @default.
• W4385751864 cites W2433987067 @default.
• W4385751864 cites W2440721038 @default.
• W4385751864 cites W2462687342 @default.
• W4385751864 cites W2482786872 @default.
• W4385751864 cites W2491008760 @default.
• W4385751864 cites W2523365393 @default.
• W4385751864 cites W2534059106 @default.
• W4385751864 cites W2534638877 @default.
• W4385751864 cites W2544261095 @default.
• W4385751864 cites W2567254792 @default.
• W4385751864 cites W2767636815 @default.
• W4385751864 cites W2780583641 @default.
• W4385751864 cites W2791655661 @default.
• W4385751864 cites W2800572937 @default.
• W4385751864 cites W2802978170 @default.
• W4385751864 cites W2809785330 @default.
• W4385751864 cites W2884027472 @default.
• W4385751864 cites W2900738171 @default.
• W4385751864 cites W2904674623 @default.
• W4385751864 cites W2907551041 @default.
• W4385751864 cites W2914729768 @default.
• W4385751864 cites W2921646015 @default.
• W4385751864 cites W2942036848 @default.
• W4385751864 cites W2952233665 @default.
• W4385751864 cites W2967146106 @default.
• W4385751864 cites W2995103612 @default.
• W4385751864 cites W3005969689 @default.
• W4385751864 cites W3007171360 @default.
• W4385751864 cites W3009986660 @default.
• W4385751864 cites W3016855528 @default.
• W4385751864 cites W3016880201 @default.
• W4385751864 cites W3024052851 @default.
• W4385751864 cites W3025218940 @default.
• W4385751864 cites W3035484455 @default.

• next